EDDC Insights
TTC Considerations in Drug Discovery
The “Considerations in Drug Discovery” video series was produced by the Target Translation Consortium (TTC) with the hope of providing critical content in an easily understandable way to aspiring drug discoverers in Singapore and beyond. The less formal, ‘fireside chat’ format aims to present the insights drawn from experts in the field in a more relatable way.
Play Video
The Importance of Target Validation | TTC Considerations in Drug Discovery Series
Play Video
Preclinical cancer-target validation: How not to be wrong
Play Video
Defining the Unmet Need | TTC Considerations in Drug Discovery Series
Play Video
Cellular assays for Target Validation | TTC Considerations in Drug Discovery Series
Play Video
In Vitro Biochemical and Biophysical Assays | TTC Considerations in Drug Discovery Series
Play Video
A Medicinal Chemist’s Perspective | TTC Considerations in Drug Discovery Serie
Play Video
Discovery and Development of Bio-Therapeutics | TTC Considerations in Drug Discovery SeriesTitle
Play Video
Considerations in the Development of Cell Therapy | TTC Considerations in Drug Discovery Series
Play Video
In Vivo Models in Drug Discovery | TTC Considerations in Drug Discovery Series
Navigating the Drug Discovery Journey
EDDC organized a drug discovery and development symposium on 15-16th May 2023 where speakers from EDDC and industry covered a wide range of topics on considerations in small and large molecule drug development. We are providing recordings of some of the talks given for a limited time. Do note that some talks have not been included as we did not have the permissions to record and make them publicly available.
Carol Koh – Target Validation in Early Drug Discovery
Christophe Bodenreider – Hit Discovery & Validation Strategies
Joseph Cherian – A Hit is Not a Lead: A Medicinal Chemist’s Perspective
Klement Foo – Emerging Small Molecule Approaches
Lim Wan Hsin – Targeting RNA with Small Molecules
Wan Kah Fei – Exploring the Realm of Large Molecule Drugs: From Target to Lead Perspective
Snow Lee – New Horizons in Antibody Modalities for Targeted Therapy
Detlev Mennerich – Starting w/ the End in Mind 1: Boehringer Ingelheim’s Approach to External Innov.
Michael Wong – The Importance of Developing a Biomarker & Translational Strategy in Early Drug Discovery
Hannes Hentze – Preclinical In Vivo Studies
Kantharaj Ethirajulu – Preclinical Development
Katherine Wang – Singapore Therapeutics Development Review (STDR)
Navigating the Drug Frontier
Integrated IP Strategy for Platform Technologies and their Products | Mewburn Ellis, 25 Jan 2024
Quick Guide for Projects with Medicinal Chemistry Needs
Preclinical in vivo Studies for Drug Discovery and Development